Cuba FDF Registrations Overview

This dashboard presents an analysis of Finished Dosage Form (FDF) registrations in Cuba, highlighting trends in holder and manufacturer countries, brand diversity, and registration lifecycles. The data reflects both domestic and international participation in the Cuban pharmaceutical market.

Global Participation and Market Spread

Cuba’s FDF registration landscape demonstrates significant international collaboration. Registrations are driven by a mix of domestic Cuban companies as well as global manufacturers from countries including the USA, India, Switzerland, and Panama. The diversity of holder countries, from Panama to Spain and Belarus—illustrates the wide geographic distribution of regulatory activity.

Brand and Product Diversity

The registrations span a variety of brands and therapeutic categories, from cardiovascular to dermatology and analgesics. While each brand generally has a single registration, the overall product coverage indicates a moderately diverse portfolio with multiple therapeutic areas represented.

Registration Lifecycles

With an average registration expiry of approximately 967 days, the Cuban market exhibits long-term product protection, allowing manufacturers sufficient time to establish market presence and manage product lifecycle strategies.

Key Takeaways

Panama-based holders show the highest engagement in Cuba, reflecting strong regional influence, while Spain and India represent significant international contributors.

The Cuban FDF ecosystem features a balanced mix of domestic and international brands, providing both local access and global product variety.

Long registration lifecycles indicate that market entry in Cuba is planned with strategic timelines, supporting sustained product availability and regulatory compliance.

Overall, the data illustrates a globally integrated registration environment, with Cuba serving as both a local and regional hub for finished dosage forms.